Imbria Pharmaceuticals, Inc.
5 clinical trials · Sponsor
◉ Watch Imbria Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (NCT07023614) | Imbria Pharmaceuticals, Inc. | 2025-10-06 |
| Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia) (NCT04826172) | Imbria Pharmaceuticals, Inc. | 2021-04-23 |
| IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2) (NCT04826159) | Imbria Pharmaceuticals, Inc. | 2021-04-21 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina (NCT04306237) | Imbria Pharmaceuticals, Inc. | 2020-05-01 |
Track Imbria Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.